RevMAb Biosciences USA, Inc is a biotechnology company focused on the development of monoclonal antibodies using a revolutionary technology that does not require cell fusion and hybridoma generation. Our rabbit and goat monoclonal antibodies are developed from a broad range of antigen-specific B cells that are inaccessible to traditional hybridoma technology. After extensive screening and clone selection, our antibodies are purified and recombinantly produced from an animal origin-free source.
With years of experience and strong expertise in antibody development, RevMAb’s team of scientists aim to revolutionize antibody generation and develop high quality products. Our mission is to promote personal health by accelerating biomedical research and advancing disease diagnosis. We seek to accomplish this by providing superior monoclonal antibodies to our customers in the research and diagnostic fields.
